Downes M, Burke L J, Bailey P J, Muscat G E
University of Queensland, Centre for Molecular and Cellular Biology, Ritchie Research Laboratories, St Lucia, Australia.
Nucleic Acids Res. 1996 Nov 15;24(22):4379-86. doi: 10.1093/nar/24.22.4379.
Rev-erbA alpha and RVR/Rev-erb beta/BD73 are orphan steroid receptors that have no known ligands in the 'classical sense'. These 'orphans' do not activate transcription, but function as dominant transcriptional silencers. The thyroid hormone receptor (TR) and the retinoic acid receptor (RAR) act as transcriptional silencers by binding corepressors (e.g. N-CoR/RIP13 and SMRT/TRAC-2) in the absence of ligands. The molecular basis of repression by orphan receptors, however, remains obscure, and it is unclear whether these corepressors mediate transcriptional silencing by Rev-erbA alpha and RVR. Recently, two new variants of N-CoR have been described, RIP13a and RIP13delta1. The characterisation of these splice variants has identified a second receptor interaction domain (ID-II), in addition to the previously characterised interaction domain (ID-I). This investigation utilised the mammalian two hybrid system and transfection analysis to demonstrate that Rev-erbA alpha and RVR will not efficiently interact with either ID-I or ID-II separately from RIP13a or RIP13delta1. However, they interact efficiently with a domain composed of ID-I and ID-II from RIP13a. Interestingly, the interaction of Rev-erbA alpha and RVR is strongest with ID-I and ID-II from RIP13delta1. Detailed deletion analysis of the orphan receptor interaction with RIP13/N-CoR rigorously demonstrated that the physical association was critically dependent on an intact E region of Rev-erbA alpha and RVR. Over-expression of the corepressor interaction domains (i.e. dominant negative forms of N-CoR/RIP13) could alleviate orphan receptor-mediated repression of transactivation by GALVP16. This demonstrated that these regions could function as anti-repressors. In conclusion, these data from two independent approaches demonstrate that repression by Rev-erbA alpha and RVR is mediated by an interaction of ID-I and ID-II of N-CoR, RIP13a and delta1 with the putative ligand binding domain of the orphan receptors.
Rev-erbAα和RVR/Rev-erbβ/BD73是“传统意义上”没有已知配体的孤儿类固醇受体。这些“孤儿”不激活转录,而是作为显性转录沉默因子发挥作用。甲状腺激素受体(TR)和视黄酸受体(RAR)在没有配体的情况下通过结合共抑制因子(如N-CoR/RIP13和SMRT/TRAC-2)作为转录沉默因子。然而,孤儿受体介导的抑制作用的分子基础仍然不清楚,并且尚不清楚这些共抑制因子是否介导Rev-erbAα和RVR的转录沉默。最近,已经描述了N-CoR的两种新变体,RIP13a和RIP13δ1。这些剪接变体的表征除了先前表征的相互作用结构域(ID-I)之外,还鉴定出了第二个受体相互作用结构域(ID-II)。本研究利用哺乳动物双杂交系统和转染分析来证明,Rev-erbAα和RVR不会分别与RIP13a或RIP13δ1的ID-I或ID-II有效相互作用。然而,它们与来自RIP13a的由ID-I和ID-II组成的结构域有效相互作用。有趣的是,Rev-erbAα和RVR与RIP13δ1的ID-I和ID-II的相互作用最强。对孤儿受体与RIP13/N-CoR相互作用的详细缺失分析严格证明,这种物理结合关键取决于Rev-erbAα和RVR完整的E区域。共抑制因子相互作用结构域(即N-CoR/RIP13的显性负性形式)的过表达可以减轻孤儿受体介导的GALVP16反式激活的抑制作用。这表明这些区域可以作为抗抑制因子发挥作用。总之,来自两种独立方法的数据表明,Rev-erbAα和RVR的抑制作用是由N-CoR、RIP13a和δ1的ID-I和ID-II与孤儿受体的假定配体结合结构域的相互作用介导的。